Conclusion
Chronic otitis externa is often a recalcitrant problem and a challenge for the attending doctor. A successful management requires investigation of underlying cause and a strategy equipped with mixture of old and new therapies. We present a study analysing the potential benefit of Flixonase® in resistant chronic otitis externa cases. All patients (100%) who returned to follow up showed cure, having previously failed with a multitude of conventional management options. We did have some limitations which we hope could be analysed further with a more robustly designed study, however the use of fluticasone propionate is an exciting and potentially important tool in the arsenal of the otolaryngologist.

Full informed consent was obtained from all patients prior to data collection. All patient data was anonymised prior to data analysis